New proposed clinico-radiologic and molecular criteria in hypochondroplasia

FGFR 3 gene mutations are not the only cause of hypochondroplasia

Sang Heon Song, Gracia Cielo Estrera Balce, Mandar Vikas Agashe, Hanna Lee, Suk-Joo Hong, Young Eun Park, Sang Gyun Kim, Hae Ryong Song

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We applied a comprehensive set of clinical and radiological criteria for the diagnosis of hypochondroplasia (HCH) in 160 patients with short stature 58 of whom were diagnosed to have HCH. Taking into account the genotypic and phenotypic variations in HCH, we conducted a study with these 58 patients and tested them for mutations in the fibroblast growth factor receptor 3 (FGFR3) and the short stature homeobox (SHOX) gene. We characterized the phenotypes by clinical and radiologic findings. In the patients with HCH, 19 were included in Group I (FGFR3 mutations-mutations of definite significance), and 39 were in Group II (6 SHOX mutations and 33 negative for disease-causing FGFR3 mutations). The clinical findings were similar in two groups regardless of the presence or absence of mutations. More than 95% of the patients had mesomelic proportions. In Group I, the radiological findings of mesomelia of upper and lower limbs and, L1/L4 ratio in anterior-posterior and lateral view were more typical than in Group II. This study proposes comprehensive clinico-radiological criteria for the diagnosis of HCH, which would help in detecting the true incidence of this underdiagnosed condition. The presence of SHOX mutations suggest genotypic-phenotypic overlap between HCH and Leri-Weill dyschondrosteosis, though further investigation is needed to effectively elucidate the importance of these mutations. Also, the 56.9% of HCH patients with negative mutations for FGFR3 suggests that there are other undiscovered gene mutations associated with this phenotypic entity.

Original languageEnglish
Pages (from-to)2456-2462
Number of pages7
JournalAmerican Journal of Medical Genetics, Part A
Volume158 A
Issue number10
DOIs
Publication statusPublished - 2012 Oct 1

Fingerprint

Mutation
Receptor, Fibroblast Growth Factor, Type 3
Genes
Homeobox Genes
Hypochondroplasia
Lower Extremity
Phenotype
Incidence

Keywords

  • Achondroplasia
  • Heterogeneity
  • Hypochondroplasia
  • Phenotypic overlap

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

New proposed clinico-radiologic and molecular criteria in hypochondroplasia : FGFR 3 gene mutations are not the only cause of hypochondroplasia. / Song, Sang Heon; Balce, Gracia Cielo Estrera; Agashe, Mandar Vikas; Lee, Hanna; Hong, Suk-Joo; Park, Young Eun; Kim, Sang Gyun; Song, Hae Ryong.

In: American Journal of Medical Genetics, Part A, Vol. 158 A, No. 10, 01.10.2012, p. 2456-2462.

Research output: Contribution to journalArticle

Song, Sang Heon ; Balce, Gracia Cielo Estrera ; Agashe, Mandar Vikas ; Lee, Hanna ; Hong, Suk-Joo ; Park, Young Eun ; Kim, Sang Gyun ; Song, Hae Ryong. / New proposed clinico-radiologic and molecular criteria in hypochondroplasia : FGFR 3 gene mutations are not the only cause of hypochondroplasia. In: American Journal of Medical Genetics, Part A. 2012 ; Vol. 158 A, No. 10. pp. 2456-2462.
@article{9482a7dc474e4f828a8a6016435b091b,
title = "New proposed clinico-radiologic and molecular criteria in hypochondroplasia: FGFR 3 gene mutations are not the only cause of hypochondroplasia",
abstract = "We applied a comprehensive set of clinical and radiological criteria for the diagnosis of hypochondroplasia (HCH) in 160 patients with short stature 58 of whom were diagnosed to have HCH. Taking into account the genotypic and phenotypic variations in HCH, we conducted a study with these 58 patients and tested them for mutations in the fibroblast growth factor receptor 3 (FGFR3) and the short stature homeobox (SHOX) gene. We characterized the phenotypes by clinical and radiologic findings. In the patients with HCH, 19 were included in Group I (FGFR3 mutations-mutations of definite significance), and 39 were in Group II (6 SHOX mutations and 33 negative for disease-causing FGFR3 mutations). The clinical findings were similar in two groups regardless of the presence or absence of mutations. More than 95{\%} of the patients had mesomelic proportions. In Group I, the radiological findings of mesomelia of upper and lower limbs and, L1/L4 ratio in anterior-posterior and lateral view were more typical than in Group II. This study proposes comprehensive clinico-radiological criteria for the diagnosis of HCH, which would help in detecting the true incidence of this underdiagnosed condition. The presence of SHOX mutations suggest genotypic-phenotypic overlap between HCH and Leri-Weill dyschondrosteosis, though further investigation is needed to effectively elucidate the importance of these mutations. Also, the 56.9{\%} of HCH patients with negative mutations for FGFR3 suggests that there are other undiscovered gene mutations associated with this phenotypic entity.",
keywords = "Achondroplasia, Heterogeneity, Hypochondroplasia, Phenotypic overlap",
author = "Song, {Sang Heon} and Balce, {Gracia Cielo Estrera} and Agashe, {Mandar Vikas} and Hanna Lee and Suk-Joo Hong and Park, {Young Eun} and Kim, {Sang Gyun} and Song, {Hae Ryong}",
year = "2012",
month = "10",
day = "1",
doi = "10.1002/ajmg.a.35564",
language = "English",
volume = "158 A",
pages = "2456--2462",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - New proposed clinico-radiologic and molecular criteria in hypochondroplasia

T2 - FGFR 3 gene mutations are not the only cause of hypochondroplasia

AU - Song, Sang Heon

AU - Balce, Gracia Cielo Estrera

AU - Agashe, Mandar Vikas

AU - Lee, Hanna

AU - Hong, Suk-Joo

AU - Park, Young Eun

AU - Kim, Sang Gyun

AU - Song, Hae Ryong

PY - 2012/10/1

Y1 - 2012/10/1

N2 - We applied a comprehensive set of clinical and radiological criteria for the diagnosis of hypochondroplasia (HCH) in 160 patients with short stature 58 of whom were diagnosed to have HCH. Taking into account the genotypic and phenotypic variations in HCH, we conducted a study with these 58 patients and tested them for mutations in the fibroblast growth factor receptor 3 (FGFR3) and the short stature homeobox (SHOX) gene. We characterized the phenotypes by clinical and radiologic findings. In the patients with HCH, 19 were included in Group I (FGFR3 mutations-mutations of definite significance), and 39 were in Group II (6 SHOX mutations and 33 negative for disease-causing FGFR3 mutations). The clinical findings were similar in two groups regardless of the presence or absence of mutations. More than 95% of the patients had mesomelic proportions. In Group I, the radiological findings of mesomelia of upper and lower limbs and, L1/L4 ratio in anterior-posterior and lateral view were more typical than in Group II. This study proposes comprehensive clinico-radiological criteria for the diagnosis of HCH, which would help in detecting the true incidence of this underdiagnosed condition. The presence of SHOX mutations suggest genotypic-phenotypic overlap between HCH and Leri-Weill dyschondrosteosis, though further investigation is needed to effectively elucidate the importance of these mutations. Also, the 56.9% of HCH patients with negative mutations for FGFR3 suggests that there are other undiscovered gene mutations associated with this phenotypic entity.

AB - We applied a comprehensive set of clinical and radiological criteria for the diagnosis of hypochondroplasia (HCH) in 160 patients with short stature 58 of whom were diagnosed to have HCH. Taking into account the genotypic and phenotypic variations in HCH, we conducted a study with these 58 patients and tested them for mutations in the fibroblast growth factor receptor 3 (FGFR3) and the short stature homeobox (SHOX) gene. We characterized the phenotypes by clinical and radiologic findings. In the patients with HCH, 19 were included in Group I (FGFR3 mutations-mutations of definite significance), and 39 were in Group II (6 SHOX mutations and 33 negative for disease-causing FGFR3 mutations). The clinical findings were similar in two groups regardless of the presence or absence of mutations. More than 95% of the patients had mesomelic proportions. In Group I, the radiological findings of mesomelia of upper and lower limbs and, L1/L4 ratio in anterior-posterior and lateral view were more typical than in Group II. This study proposes comprehensive clinico-radiological criteria for the diagnosis of HCH, which would help in detecting the true incidence of this underdiagnosed condition. The presence of SHOX mutations suggest genotypic-phenotypic overlap between HCH and Leri-Weill dyschondrosteosis, though further investigation is needed to effectively elucidate the importance of these mutations. Also, the 56.9% of HCH patients with negative mutations for FGFR3 suggests that there are other undiscovered gene mutations associated with this phenotypic entity.

KW - Achondroplasia

KW - Heterogeneity

KW - Hypochondroplasia

KW - Phenotypic overlap

UR - http://www.scopus.com/inward/record.url?scp=84866516374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866516374&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.35564

DO - 10.1002/ajmg.a.35564

M3 - Article

VL - 158 A

SP - 2456

EP - 2462

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 10

ER -